William S Denney

8PUBLICATIONS
29CO-AUTHORS
PharmacogenomicsMedical molecular engineering of nucleic acids and proteinsReaction engineering (excl. nuclear reactions)NanophotonicsVeterinary anaesthesiology and intensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 19, 2025
Population Pharmacokinetics and Exposure-Response Analyses of Sarilumab in Patients with Polymyalgia Rheumatica.

Christine Xu, William S Denney, Ying Liu

|May 18, 2024
First-in-human safety, tolerability, and pharmacokinetic results of DFV890, an oral low-molecular-weight NLRP3 inhibitor.

Ewa Gatlik, Beata Mehes, Emilie Voltz

|Sep 28, 2023
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial.

Jerry Vockley, Neal Sondheimer, Marja Puurunen

|Aug 16, 2022
Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.

Marja K Puurunen, Jerry Vockley, Shawn L Searle

|Jul 23, 2021
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.

Marja K Puurunen, Jerry Vockley, Shawn L Searle

|Jul 23, 2021
Development of a mechanistic model to predict synthetic biotic activity in healthy volunteers and patients with phenylketonuria.

Mark R Charbonneau, William S Denney, Nicholas G Horvath

Pageof 2

Frequent Collaborators

4 joint publications

Caroline Kurtz

3 joint publications

Marja Puurunen

3 joint publications

Mark R Charbonneau

1 joint publications

Ewa Gatlik